Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621306 · ClinicalTrials.gov registry record
DXA Study of Precision and Reliability
A clinical trial of Body Composition and Bone and Bones, sponsored by Penn State University.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT03621306: Recruiting study of Body Composition and Bone and Bones, sponsored by Penn State University.
NCT03621306 is a study of Body Composition and Bone and Bones that is actively recruiting participants, run by Penn State University. The registered enrollment target is 400 participants, above the 96-participant average among 20 other Body Composition trials with a reported enrollment target (317% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03621306, a study of Body Composition and Bone and Bones, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to assess precision of the GE Lunar iDXA, Hologic Horizon W DXA scanner, and the Stratec peripheral quantitative computed tomography (pQCT) scanner. Aim 1: To assess standard deviation (SD) and coefficient of variation (CV) of testing bone mineral, bone geometry, and soft tissues in inanimate objects and adults. Tests on adults will be structured to assess: 1. Within- and between-day variability of testing 2. Within- and between-technician variability of testing 3. Variability due to positioning and post-scan processing 4. Variability due to different DXA scanning equipment Aim 2: To assess the least significant change (LSC) for testing bone mineral and soft tissues in adults. Aim 3: To assess strengths and limitations of DXA and pQCT testing, including sensitivity to movement, rate of re-rescanning, etc. which are crucial components for demonstrating feasibility in grant applications. Aim 4: To construct a database of DXA and pQCT test results and quality control procedures, showing our laboratory's quality control level.
Primary Outcome
Standard Deviation and coefficient of variation for BMD measurements obtained on the GE Lunar iDXA
Conditions Studied
Interventions
- DEVICE DXA and pQCT precision testing
Study Locations (1)
Pennsylvania
- Women's Health and Exercise Laboratories, The Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-06-16 |
| Est. Completion | 2028-08-31 |
What NCT03621306 shows while recruiting
NCT03621306 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 20 other Body Composition trials with a reported enrollment target (317% higher).
The record links to 2 conditions, with Body Composition appearing as the primary indexed condition, and to 1 intervention - of which DXA and pQCT precision testing is the first listed.
NCT03621306 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03621306 about?
NCT03621306 is a clinical study titled "DXA Study of Precision and Reliability". The purpose of the study is to assess precision of the GE Lunar iDXA, Hologic Horizon W DXA scanner, and the Stratec peripheral quantitative computed tomography (pQCT) scanner. Aim 1: To assess standard deviation (SD) and coefficient of variation (CV) of testing bone mineral, bone geometry, and sof...
What is the current status of trial NCT03621306?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2008-06-16. Estimated completion is 2028-08-31.
What conditions does trial NCT03621306 study?
This clinical trial studies the following conditions: Body Composition, Bone and Bones.
What interventions are being tested in trial NCT03621306?
The interventions under investigation include: DXA and pQCT precision testing (DEVICE).
Who is sponsoring clinical trial NCT03621306?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03621306 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Composition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03621306's enrollment target sits among peer trials
400 2nd of 20 the highest of 20 other Body Composition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Body Composition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
How Does Continued Use of Green Light Therapy Impact Outcomes?
RECRUITING · NA
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
RECRUITING
-
Can EmeraldLED Reshape Your Body With Continued Use?
RECRUITING · NA
-
Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI